| A functional role for antibodies in tuberculosis LL Lu, AW Chung, TR Rosebrock, M Ghebremichael, WH Yu, PS Grace, ... Cell 167 (2), 433-443. e14, 2016 | 591 | 2016 |
| Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines AW Chung, M Ghebremichael, H Robinson, E Brown, I Choi, S Lane, ... Science translational medicine 6 (228), 228ra38-228ra38, 2014 | 453 | 2014 |
| Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology AW Chung, MP Kumar, KB Arnold, WH Yu, MK Schoen, LJ Dunphy, ... Cell 163 (4), 988-998, 2015 | 377 | 2015 |
| Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 AK Wheatley, JA Juno, JJ Wang, KJ Selva, A Reynaldi, HX Tan, WS Lee, ... Nature communications 12 (1), 1162, 2021 | 376 | 2021 |
| Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1 WF Garcia-Beltran, A Hölzemer, G Martrus, AW Chung, Y Pacheco, ... Nature immunology 17 (9), 1067-1074, 2016 | 256 | 2016 |
| Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity M Koutsakos, AK Wheatley, L Loh, EB Clemens, S Sant, S Nüssing, A Fox, ... Science translational medicine 10 (428), eaan8405, 2018 | 244 | 2018 |
| Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition M Vaccari, SN Gordon, S Fourati, L Schifanella, NPM Liyanage, ... Nature medicine 22 (7), 762-770, 2016 | 218 | 2016 |
| Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine Y Ju, WS Lee, EH Pilkington, HG Kelly, S Li, KJ Selva, KM Wragg, ... Acs Nano 16 (8), 11769-11780, 2022 | 212 | 2022 |
| Role of IgG3 in infectious diseases T Damelang, SJ Rogerson, SJ Kent, AW Chung Trends in immunology 40 (3), 197-211, 2019 | 197 | 2019 |
| Antigen-specific antibody glycosylation is regulated via vaccination AE Mahan, MF Jennewein, T Suscovich, K Dionne, J Tedesco, AW Chung, ... PLoS pathogens 12 (3), e1005456, 2016 | 178 | 2016 |
| Systems serology detects functionally distinct coronavirus antibody features in children and elderly KJ Selva, CE Van De Sandt, MM Lemke, CY Lee, SK Shoffner, BY Chua, ... Nature communications 12 (1), 2037, 2021 | 175* | 2021 |
| Specific antibody‐dependent cellular cytotoxicity responses associated with slow progression of HIV infection LH Wren, AW Chung, G Isitman, AD Kelleher, MS Parsons, J Amin, ... Immunology 138 (2), 116-123, 2013 | 170 | 2013 |
| Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure AW Chung, G Isitman, M Navis, M Kramski, RJ Center, SJ Kent, I Stratov Proceedings of the National Academy of Sciences 108 (18), 7505-7510, 2011 | 167 | 2011 |
| Integrated immune dynamics define correlates of COVID-19 severity and antibody responses M Koutsakos, LC Rowntree, L Hensen, BY Chua, CE Van De Sandt, ... Cell Reports Medicine 2 (3), 2021 | 154 | 2021 |
| Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001) DH Barouch, J Liu, L Peter, P Abbink, MJ Iampietro, A Cheung, G Alter, ... The Journal of infectious diseases 207 (2), 248-256, 2013 | 133 | 2013 |
| Activation of NK cells by ADCC antibodies and HIV disease progression AW Chung, M Navis, G Isitman, L Wren, J Silvers, J Amin, SJ Kent, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 58 (2), 127-131, 2011 | 131 | 2011 |
| Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function AW Chung, M Crispin, L Pritchard, H Robinson, MK Gorny, X Yu, ... Aids 28 (17), 2523-2530, 2014 | 130 | 2014 |
| Rapid degranulation of NK cells following activation by HIV-specific antibodies AW Chung, E Rollman, RJ Center, SJ Kent, I Stratov The Journal of Immunology 182 (2), 1202-1210, 2009 | 130 | 2009 |
| Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects I Stratov, A Chung, SJ Kent Journal of virology 82 (11), 5450-5459, 2008 | 129 | 2008 |
| Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice P Pymm, A Adair, LJ Chan, JP Cooney, FL Mordant, CC Allison, E Lopez, ... Proceedings of the National Academy of Sciences 118 (19), e2101918118, 2021 | 128 | 2021 |